Konstantinos Chiotis
Affiliations: | Karolinska Institute, Stockholm, Sweden |
Area:
Alzheimer's disease. Positron Emission TomographyGoogle:
"Konstantinos Chiotis"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ove Almkvist | grad student | 2013-2017 | Karolinska |
| Stephen F. Carter | grad student | 2013-2017 | University of Manchester |
| Agneta Nordberg | grad student | 2013-2017 | Karolinska |
| Laure Saint-Aubert | grad student | 2013-2017 | Karolinska |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rodriguez-Vieitez E, Kumar A, Malarte ML, et al. (2024) Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Methods in Molecular Biology (Clifton, N.J.). 2785: 195-218 |
| Chiotis K, Johansson C, Rodriguez-Vieitez E, et al. (2023) Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP. Molecular Neurodegeneration. 18: 60 |
| Bucci M, Bluma M, Savitcheva I, et al. (2023) Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic. Translational Psychiatry. 13: 268 |
| Fontana IC, Scarpa M, Malarte ML, et al. (2023) Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective. Cells. 12 |
| Oeckl P, Bluma M, Bucci M, et al. (2023) Blood β-synuclein is related to amyloid PET positivity in memory clinic patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Bucci M, Chiotis K, Nordberg A, et al. (2021) Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Molecular Psychiatry |
| Boccardi M, Dodich A, Albanese E, et al. (2021) Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging |
| Colato E, Chiotis K, Ferreira D, et al. (2021) Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Chiotis K, Dodich A, Boccardi M, et al. (2021) Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging |
| Boccardi M, Dodich A, Albanese E, et al. (2021) The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging |